MicroRNAs in mouse models of lymphoid malignancies

Submitted: 27 February 2010
Accepted: 12 May 2010
Published: 25 May 2010
Abstract Views: 1553
PDF: 662
HTML: 1064
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The discovery of microRNAs (miRNAs) has revealed a new layer of gene expression regulation that affects many normal and pathologic biological systems. Among the malignancies affected by the dysregulation of miRNAs there are cancers of lymphoid origin, in which miRNAs are thought to have tumor suppressive or tumor promoting activities, depending on the nature of their specific targets. In the last 4-5 years, the experimental field that provided the deepest insights into the in vivo biology of miRNAs is that of mouse modeling in which transgenic and knockout animals mimic, respectively, over-expression or down-regulation of specific miRNAs involved in human leukemia/lymphoma. This review discusses recent advances in our understanding of lymphoid malignancies based on the natural and engineered mouse models of three different miRNAs, miR-15a/16-1 cluster, miR-155, and miR-17-92 cluster.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Supporting Agencies

Kimmel Foundation for Cancer Research

How to Cite

Zanesi, N. A., Pekarsky, Y., Trapasso, F., Calin, G., & Croce, C. M. (2010). MicroRNAs in mouse models of lymphoid malignancies. Journal of Nucleic Acids Investigation. https://doi.org/10.4081/jnai.1727

Similar Articles

You may also start an advanced similarity search for this article.